Corporate PresentationDownload Presentation Wednesday, November 29, 2023 | 3:10 – 3:30 p.m. ETPiper Sandler 35th Annual Healthcare ConferenceAccess Webcast »Tuesday, November 14, 2023 | 9:10 – 9:40 a.m. ETStifel 2023 Healthcare ConferenceAccess Webcast »Tuesday, October 31, 20237th Annual Dermatology Drug Development SummitView Presentation »Tuesday, October 17, 2023International Conference of the Inflammation Research Association (IRA)View Presentation » Latest Press ReleasesNovember 9, 2023Recludix Pharma to Present at Two Investor Conferences in NovemberRead More »October 31, 2023Recludix Pharma Presents Preclinical Data Demonstrating Strong Efficacy and Favorable Safety Profile of REX-7117 Versus TYK2 and JAK Inhibitors at the Dermatology Drug Development SummitRead More »October 17, 2023Recludix Pharma Presents Preclinical Data from its STAT3 Inhibitor Program at the International Conference of the Inflammation Research Association (IRA)Read More »August 30, 2023Recludix Pharma to Participate in Multiple Investor Conferences in SeptemberRead More » More Press Releases News Coverage HighlightsAugust 7, 2023BioCentury: Recludix: targeting STATs via their SH2 domainsRead More »July 20, 2023BioWorld: Recludix enters a potential $1.2B deal with SanofiRead More »July 20, 2023SCRIP: Sanofi Adds To Immunology Pipeline In Collaboration With Recludix Read More »July 20, 2023Fierce Biotech: Sanofi pays $125M to go after undruggable inflammatory target with Recludix’s preclinical programRead More »July 20, 2023Endpoints News: Following Dupixent’s rise, Sanofi heads downstream in immunology for $125M small molecule pact with RecludixRead More »
